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Abstract 
Purpose: To fabricate and evaluate oral 2-hydroxyethyl methacrylate-co-acrylic acid hydrogels as a 
drug delivery system for sustained release of nicorandil. 
Methods: HEMA-co-AA hydrogels using different monomer concentrations were prepared by free 
radical polymerization. N, N-methylene bis acrylamide (MBA) was used as crosslinker and potassium 
persulphate (KPS) as initiator. Nicorandil (20 mg) loaded hydrogels were characterized by Fourier 
transform infrared spectroscopy (FTIR), thermogravimetric  analysis and differential scanning 
calorimetry (DSC) and scanning electron microscopy (SEM) . Swelling ratio, equilibrium swelling (ES), 
gel content (gc), porosity measurement (P) and in vitro drug release of the delivery system were 
evaluated. 
Results: Swelling ratio and ES decreased as AA concentration (%) was reduced from 3.173 to 2.93 (pH 
1.2) and 16.42 to 15.01 (pH 7.4) and 68.49 to 65.90 (pH 1.2) and 93.91 to 93.34 (pH 7.4), respectively, 
while HEMA and MBA showed opposite effects. Gel content (%) and porosity (%) ranged from 83.76 to 
88.0, respectively from F1 to F9. With increase monomer content (AA), drug release increased from 
85.99 to 89.38 %. However, when the concentrations of HEMA and MBA were raised, drug release 
decreased.  
Conclusion: HEMA-co-AA hydrogels are potential pH-sensitive and sustained-release system for 
nicorandil. 
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Due to health-related dysfunctions, drug delivery 
to target site at therapeutic levels for a prolonged 
period is a major objective. However, the action 
of pharmaceutical agents is confined by several 
factors including drug degradation, interaction 
with cells and inability to infiltrate tissues. These 
factors provide the basis for developing carrier 
systems with the desired release profile with 
regard to time and drug distribution [1]. For oral 
controlled release drug delivery systems 
hydrophilic gel forming polymeric systems are 
extensively used to achieve the anticipated drug 
release profile, cost effectiveness and broad 
regulatory acceptance [2]. 
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Graft copolymers have been extensively used to 
formulate a number of controlled release 
systems such as hydrogels, microspheres, matrix 
tablets. ‘Grafting’ refers to a technique in which 
monomers are covalently bonded onto the 
polymer chain. Graft copolymerization can 
change the properties of polymer. These are 
extensively used in various areas such as 
dyeing, printing, fiber strength, chemical 
resistance, water repellency, crease resistance 
and abrasion resistance [3]. Grafting imparts the 
desired modifications in reactants during 
preparation. These grafted co-polymeric systems 
are of great interest as they can be formulated 
into various stimuli-dependent controlled release 
drug delivery systems [4]. 
 
Nicorandil, a nicotinamide derivative, is an 
efficacious remedy in the management of 
hypertension and angina pectoris. As a 
potassium channel opener, it causes 
vasodilatation of arterioles and large coronary 
arteries. Venous vasodilatation is attributed to its 
nitrate component [5].  The aim of this study was 
to prepare 2-hydroxyethyl methacrylate-co-
acrylic acid hydrogels and to formulate a 
hydrogel drug delivery system for prolonged drug 






Acrylic acid (99 %) was purchased from Sigma 
Aldrich-Netherlands; 2-hydroxyethyl methacrylate 
(97 %) from Sigma Aldrich-Germany and N, N 
methylene-bis-] acrylamide (98 %) purchased 
from Fluka-Switzerland. Potassium persulphate 
(99 %, AnalaR, BDH, England), potassium 
dihydrogen phosphate (98 - 100 %, Merck, 
Germany), absolute ethanol (Merck, Germany), 
and nicorandil (99.8 %, a gift from Getz Pharma-
Pakistan) were also used in the study. 
 
Synthesis of hydrogel by free radical 
polymerization  
 
Hydrogels were prepared by free radical 
polymerization. Acrylic acid solution was placed 
on a hot plate with a magnetic stirrer at 70 °C 
and stirring was continued at 300 rpm. Initiator 
(KPS) solution was added drop wise to the 
solution at the same temperature and stirring 
speed. These conditions were maintained for 10 
min, and the solution allowed to cool down to 
room temperature. 2-Hydroxyethyl methacrylate 
and N, N, methylen-bis-acrylamide solution were 
added to the mixture and stirred at 300 rpm for 1 
- 2 min before maintaining at 80 oC for 3 h in a 
water bath to allow polymerization. The resulting 
hydrogel was cut into small discs of 4 mm 
thickness with a sharp cutter, washed with 
distilled water, placed in an ethanol: water 
(50:50) mixture for 24 h before drying in an oven 




Swelling studies were performed at pH 1.2, 5.8 
and 7.4 till swelling equilibrium, at prescheduled 
time points. A weighed disc of the formulation 
was socked in 100 ml buffer of pH 1.2, 5.8 and 
7.4 separately. At specific time points, the discs 
were dried by using blotting paper and weighed 
with an analytical balance. 
 
Dynamic swelling and equilibrium swelling ratios 
of all formulations were determined using Eq 1. 
 
Q = Wh/Wd ………………………………….. (1) 
 
where “q” is dynamic swelling, Wh shows swollen 
gel’s weight at time t and Wd shows initial weight 
of dried hydrogel disc [6]. 
 
Equilibrium swelling measurement 
 
Swelling measurement was carried out until 
equilibrium weight of the gel was achieved. 
Equilibrium swelling was calculated as shown in 
Eq 2. 
 
ES (%) = (Meq – Mo)/Meq x 100 …………. (2) 
 
Where Meq = mass of the swollen gel at 
equilibrium and Mo the mass of dried gel disc [7]. 
 
Gel content determination 
 
Freshly prepared hydrogel disc of 4 mm 
thickness (was subjected to vacuum oven drying 
at 45 oC to a constant weight (Wo). Then 
extraction was performed with deionized water 
for 24 h. Non reacted polymer/monomer was 
washed away via this extraction. The disk was 
again dried in oven at 45 oC till constant weight 
(W1). % gel content was determined by equation 
3. 
 
% gc = (W1/Wo) x 100 …………………… (3) 
 
where W1 is the weight of dry gel after extraction 
in distilled water and Wo is the initial weight of the 




This entailed computing the fraction of voids 
volume over total volume between 0 and 1 or in 
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case of percent between 0 to 100 % is stated as 
porosity. Solvent replacement method was 
chosen to figure out porosity measurement. The 
dried weighed hydrogel disc (Md) was immersed 
in absolute ethanol for 24 h (to constant weight). 
After 24 h hydrated hydrogel disc was blot dried 
to remove excess surface ethanol and weighed 
on analytical weight balance (Wh). Porosity (P) 
was computed as in Eq 4. 
Porosity (%) = (Mh – Md)/ ρV x 100 ……… (4) 
where ρ refers to density of absolute ethanol and 
V is hydrogel volume [9]. 
 
Drug loading determination 
 
Drug loading was determined by absorption 
method. A solution (1%) of the drug in phosphate 
buffer (pH 7.4) was prepared. One disc of each 
formulation was allowed to swell and reach 
swelling equilibrium in 100 ml of 1% drug 
solution. After swelling equilibrium was achieved, 
the discs were removed from solution, washed 
out with distilled water to remove excess surface 
drug, allowed to air-dry at room temperature and 
then dried in an oven at 40 oC to constant weight 
[10]. Drug loaded in discs was determined as in 
Eq 5. 
 
Drug loading (%) = {(WL – Wu)/Wu}100 …….. (5) 
 
where WL is weight of dried drug loaded disk and 
Wu is weight of dried unloaded disc [11]. 
 
Fourier transform infrared spectroscopy 
(FTIR) 
 
The gel formulation was subjected to Fourier 
transform infrared analyzer (Bruker, Tensor 27, 
Germany) at 25 oC to determine drug - polymer 
compatibility. In this study, attenuated total 
reflectance (ATR) technology along with OPUS 
data collection software was employed to 
analyze FTIR spectra of the samples obtained 
Bruker FTIR (Tensor 27 series, Germany) 
system in the range of 500 cm-1 - 4000 cm-1. For 
the transmission study, finely grounded solid 
sample was placed directly in the path of infrared 
(IR) beam as a thin film. 
 
Thermal gravimetric analysis (TGA) and 
differential scanning calorimetry (DSC) 
 
Dried and ground sample of formulation F1 (0.5 
g) was subjected to thermogrametric analysis 
and differential scanning calorimetry by sealing 
them in aluminum pans. Measurements were 
achieved at a rate 10 oC per min, under nitrogen 
flow of 25 ml/min, in the temperature range of 20 
to 900 oC. The standard uncertainty of the 
sample mass measurement was ± 1%. 
Equipment calibration was accomplished with 
calcium oxalate supplied with the instrument [12]. 
 
Scanning electron microscopy (SEM) 
 
The surface morphology of all combinations of 
hydrogel formulations was determined by a 
scanning electron microscope (Hitachi, S3400N). 
The samples were coated with gold by Hummer 
Sputter Coater [13]. 
 
In vitro drug release studies 
 
In vitro drug release of hydrogel discs loaded 
with nicorandil was evaluated according to the 
specifications of United States Pharmacopeia by 
using USP apparatus II. The dissolution medium 
(900 ml, 0.1 M HCl, pH 1.2, 900 ml or phosphate 
buffer, pH 7.4) used was stirred at 50 rpm at 37 
oC ± 0.5 oC, and 5 ml of aliquot was drawn at 
various intervals up to 24 h with an automated 
sample collector (T-DT7 Pharmatest, Germany), 
after filtering through sinter filters (10 µm pore 
size). After each sample withdrawal, fresh 5 ml 
medium was added to maintain sink conditions. 
The samples were diluted to 50 ml with fresh 
dissolution medium and analyzed at 225 nm 
using a UV-spectrophotometer (PTCF II Pharma 
Test, Germany). The drug release study was 




Statistical significance of difference was 
evaluated using Statistical Package for Social 






Dynamic equilibrium swelling ratios and percent 
equilibrium swelling (% ES) as depicted in Table 
2 elaborated that in acidic medium with lower 
pKa less swelling occurred as compared to basic 
medium with higher pKa where swelling was 
more. 
 
Table 1 cleared that as acrylic acid content 
increases swelling ratio and percent equilibrium 
swelling increases (F4 to F6) while both 
decreases with increase in cross linker 
concentration (F7 to F9). 
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swelling ratio (q) 
Equilibrium swelling (ES, 
%) 
   pH 
1.2 
pH 5.8 pH 7.4 pH 1.2 pH 5.8 pH 7.4 
F1 0.84 16.5 0.015 3.498 10.810 16.358 71.416 90.749 93.886 
F2 1.68 16.5 0.015 3.190 9.635 14.824 68.661 89.621 93.254 
F3 3.36 16.5 0.015 3.013 9.163 13.696 66.818 89.087 92.699 
F4 2.52 14.5 0.015 3.173 10.508 15.013 68.491 90.483 93.909 
F5 2.52 12.5 0.015 3.115 10.188 16.005 67.904 90.184 93.752 
F6 2.52 10.5 0.015 2.932 9.397 16.42 65.897 89.359 93.339 
F7 2.52 14.5 0.020 2.917 9.904 10.104 65.728 89.903 94.084 
F8 2.52 14.5 0.025 2.805 8.986 9.066 64.349 88.872 93.362 
F9 2.52 14.5 0.030 2.528 6.193 8.775 60.451 83.853 92.740 





Figure 1: Swelling kinetics of formulations with varying weight ratio 
 
In vitro drug release  
 
Overall, in vitro drug release increased with 
increase in pH from acidic to basic (Figure 2). 
 
Drug release was affected by change in 
monomer concentration and as well as by 
crosslinker concentration. At pH 7.4, drug 
release also increased with increase in acrylic 
acid concentration from 85.99 to 89.39 % (p < 
0.05) but decreased when HEMA level increased 
from 96.09 to 93.702 % (p < 0.05) and MBA 
concentration rose from 77.35 to 70.99 % (p < 
0.05). 
   
Figure 2: Cumulative release of nicorandil from 
HEMA-co-AA hydrogels 
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Gel content and porosity  
 
Percent gel content (% gc) and percent porosity 
(% P) measurements of all formulations casing 
different concentrations of components 
computed. Percent gel content ranges from 
83.758 % to 87.988 % (p < 0.05) with different 
weight ratios. While percent porosity ranges from 
14.425 % to 5.3772 % (p < 0.05) with different 
weight ratios from F1 to F9. 
 
Drug – polymer compatibility 
 
The FTIR soectra showed drug excipient 
compatibility. Characteristic peaks were found at 
3247 cm-1 for (NH); 1675 cm-1 for (C=O, CONH) 
and 1362 cm-1 for (CH2) [19]. Peaks were also 
observed at 3243.17 cm-1 for (NH); 1627.97 cm-1 
for (C=O, CONH) and 1361.55 cm-1 for (CH2). In 
pure nicorandil sample peaks were observed at 
1625.16 cm-1, 1285.90 cm-1 and 705.33 cm-1  
which are characteristic peaks of nicorandil. 
These characteristic peaks of nicorandil are also 
present in drug loaded hydrogel formulation (F1) 
showing stability of drug with hydrogel 
formulation. 
 
Morphology of hydrogels 
 
The results of scanning electron microscopy 
(SEM) are shown in Figure 4. Interconnected 
porous network structure of formulation F1 was 





    Figure 3: FTIR spectra of HEMA-co-AA hydrogel 
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Figure 4: Scanning electron micrographs (SEM) of surface of HEMA-co-AA hydrogels at magnification of 100X 




The thermal transition behavior of the 
formulations are shown in Figure 5. Formulated 
hydrogel (F4) was thermostable. Decomposition 
of formulation occurred in four steps. First, 
degradation was observed up to 275 oC with 
21.17 % weight loss due to dehydration. Second, 
another degradation took place from 275 to 400 
oC with 35.28 % weight loss and again, from 400 




The swelling behavior of the hydrogels in 
different media is controlled by various factors 
such as equilibrium water content, pKa value and 
chemical structure of formulation. At acidic pH 
carboxylic groups are protonated leading ionized 
groups in polymer chain. This results in no or 
less swelling of polymer network. At basic pH 
electrostatic repulsive forces between molecules 
resulted in expansion of polymeric network. [15]. 
In the present study, swelling ratio was varied by 
increasing monomer concentration (AA) from 
15.013 to 16.420 because of higher hydrophilic 
content in polymer chain as depicted by 
formulation F4 to F6. Whereas swelling ratio was 
decreased by increasing cross linker 
concentration ranging from 10.104 to 8.775 due 
to the establishment of close-fitted network 
structure. However, this decrease with increase 
in swelling is statistically insignificant (p < 0.05). 
 
Das also studied swelling behavior of hydrogels 
and stated that swelling ratio was increased by 
increasing monomer concentration due to 
increased hydration of polymeric network. 
Swelling ratio decreased with increasing 
crosslinker concentration due to more compact 
network formation [16].    
 
The mechanism of this release can be attributed 
to swelling of the polymer ionic network. At low 
pH, polymer ionizes resulting in formation of 
anionic centers which ultimately lead to 
domination of compact polymer interaction 
leading to a compact network. This constitutes 
hindrance to water penetration resulting in 
decreased water holding capacity and thus 
ultimately lowers drug release. At lower pH 1.2, 
no noticeable difference in release profile was 
observed. 
 
With increase in cross-linker concentration, 
ionization of carboxylic group occurs, resulting in 
formation of new crosslinked sections by 
hydrogen bonding. These electrostatic forces 
between functional groups result in compact 
arrangement of polymeric network. Ultimately, it 
leads to less swelling and low in vitro drug 
release [17]. 
 
Percent porosity was measured by pore volume 
present with in hydrogel structure while gel 
content was measured by cross linking density. 
With increasing concentration of HEMA and MBA 
percent porosity was decreased while percent 
gel content was increased. Increased gel content 
could be justified by enhanced cross linking 
density and greater physical entanglement 
resulting in less pore volume. As a result swelling 
ratio was decreased leading to decrease in in 
vitro drug release. Increased concentration of 
monomer AA resulted in less crosslinking 
density, leading to greater pore volume. As a 
result, water retention capacity and drug release 
increased. Shivani et al observed a similar 
pattern   and   explained   that   with  increase  in  
Rashid et al 
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Figure 5: Thermal transition behavior of HEMA-co-AA hydrogel 
 
crosslinking density, gel content rose while 
porosity decreased [18]. 
 
The results of this study also agree with those of 
a previous study where it was observed that 
porosity decreased with increase in crosslinking 
density [15]. 
 
Abdul & Lila have sought to analyze the FTIR 
spectra of nicorandil and their findings are in 
agreement with those of the present study [20]. 
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This porous structure is thought to be 
responsible for the swelling and drug release of 
the hydrogels. as these pores act as water 
channels and allow holding of water [18]. 
 
Decomposition of functional groups of the 
hydrogel is thought to be responsible for this 
degradation. Final degradation of hydrogel was 
observed at 550 oC with 20.71% weight loss. Das 
et al also found that the hydrogels were 
thermostable and displayed thermal 




A hydrogel formulation of nicorandil for prolonged 
drug release, and hence a capability for 
decreased dosing frequency and improved 
patient compliance, has been successfully 
developed in vitro. However, in vivo studies are 
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